Russell Investments Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$596K Buy
113,785
+82,078
+259% +$279K ﹤0.01% 2703
2026
Q1
$55.8K Sell
31,707
-1,845
-5% -$4K ﹤0.01% 3285
2025
Q4
$78.8K Sell
33,552
-409
-1% -$1.12K ﹤0.01% 3138
2025
Q3
$104K Buy
+33,961
New +$97K ﹤0.01% 3011
2025
Q1
Sell
-2,028
Closed -$6.39K 3810
2024
Q4
$6.39K Buy
+2,028
New +$7.25K ﹤0.01% 3229
2023
Q2
Sell
-1,852
Closed -$1.56K 3461
2023
Q1
$1.56K Sell
1,852
-52,948
-97% -$58K ﹤0.01% 3029
2022
Q4
$50.9K Sell
54,800
-55,000
-50% -$73.4K ﹤0.01% 2736
2022
Q3
$186K Buy
109,800
+90,200
+460% +$236K ﹤0.01% 2556
2022
Q2
$41K Buy
+19,600
New +$52.1K ﹤0.01% 2746
2020
Q4
Sell
-9,500
Closed -$118K 3061
2020
Q3
$118K Buy
+9,500
New +$105K ﹤0.01% 2944

Other funds holding CLOV

Russell Investments Group's CLOV Position: Q2 2026 in Review

Russell Investments Group increased its Clover Health Investments (CLOV) stake by 259% in Q2 2026, buying an estimated $279K and bringing the position to 113,785 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

Russell Investments Group first reported a position in CLOV in Q3 2020 and has held it in 10 quarters since. 98 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Russell Investments Group held 113,785 shares of Clover Health Investments worth $596K as of Q2 2026.
  • Russell Investments Group bought 82,078 Clover Health Investments shares in Q2 2026, an estimated $279K.
  • Clover Health Investments made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2703 holding.
  • Russell Investments Group first reported a position in Clover Health Investments in Q3 2020 and has held it in 10 quarters since.
  • 98 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.